<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Future News 24</provider_name><provider_url>https://futurenews24.com</provider_url><author_name>Future News 24</author_name><author_url>https://futurenews24.com/index.php/author/mridulpahuja20/</author_url><title>Piperazine linked chitosan schiff base nanoparticles as a novel antibiofilm and antibacterial technique towards clinically related pathogens - Future News 24</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="n60oP8DFBQ"&gt;&lt;a href="https://futurenews24.com/index.php/2026/08/06/s41598-026-63745-z/"&gt;Piperazine linked chitosan schiff base nanoparticles as a novel antibiofilm and antibacterial technique towards clinically related pathogens&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://futurenews24.com/index.php/2026/08/06/s41598-026-63745-z/embed/#?secret=n60oP8DFBQ" width="600" height="338" title="&#x201C;Piperazine linked chitosan schiff base nanoparticles as a novel antibiofilm and antibacterial technique towards clinically related pathogens&#x201D; &#x2014; Future News 24" data-secret="n60oP8DFBQ" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://futurenews24.com/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><thumbnail_url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-026-63745-z/MediaObjects/41598_2026_63745_Fig1_HTML.png</thumbnail_url><thumbnail_width>1024</thumbnail_width><thumbnail_height>1024</thumbnail_height><description>The development of multifunctional antimicrobial materials capable of targeting both planktonic bacteria and biofilm-associated infections remains a critical challenge in combating antimicrobial resistance. In this study, a novel piperazine-linked chitosan Schiff base (Cs-TPA-PiP) and its ionically crosslinked nanoparticle formulation (Cs-TPA-PiP NPs) were synthesized and structurally characterized. The antimicrobial potential of both Cs-TPA-PiP and Cs-TPA-PiP NPs was evaluated against a panel of nine standard clinically significant bacterial strains. The compounds demonstrated significant and broad-spectrum antibacterial activity. The minimum inhibitory concentration (MIC) values demonstrated potent efficacy, with Cs-TPA-PiP and its Cs-TPA-PiP NPs ranging from 0.63 to 2.50&amp;nbsp;mg/mL and 1.00&#x2013;5.00&amp;nbsp;mg/mL, respectively. Notably, both agents exhibited a strong dose-dependent inhibitory effect on biofilm formation. While Cs-TPA-PiP showed lower MIC values against planktonic cells, the corresponding Cs-TPA-PiP NPs with an ultra-small spherical size of 15.6&amp;nbsp;nm exhibited superior antibiofilm performance, ranging from 73.00% to 95.00% inhibition of biofilm biomass at 1&#xD7; MIC in strong biofilm-producing strains. Transmission electron microscopy (TEM) confirmed severe morphological alterations and membrane disruption in treated bacterial cells, consistent with a membrane-targeting mechanism. In silico molecular docking studies suggested that the compound has favorable binding affinity for the critical bacterial cell wall target, Sortase A, thereby identifying it as a potential theoretical target requiring further validation. Our findings collectively establish Cs-TPA-PiP and its Cs-TPA-PiP NPs as effective antibacterial and anti-biofilm candidates, with their activity primarily attributed to membrane disruption. The proposed role of Sortase A inhibition remains hypothetical and warrants further investigation. These findings highlight their potential as multifunctional antibacterial platforms for managing biofilm-associated and resistant bacterial infections.</description></oembed>
